PSL Filter Dryers - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PSL's Filter Dryers are designed by process experts for optimum levels of performance, safety and quality. The agitated nutsche filter dryers include specific design features for maximum productivity such as CIP (Clean-In-Place) and reflux cleaning achieving typically less than 2.5ppm; unique underplate heating systems for highly efficient drying; tapered filter plates and seal design enabling minimum product retention; and totally sealed single piece agitators with differential mixing providing homogeneity and uniformed drying.

PSL’s High Containment Glovebox Isolators can be incorporated for the safe handling of highly potent APIs or Cytotoxic compounds. This total process solution enables safe product offloading, contained sampling and total heel recovery for maximum product yield, all designed and integrated by PSL.

PSL’s filter dryers range from lab scale synthesis applications, Kilo-lab and Pilot plant operations to large scale commercial production, for easy and direct scale-up of chemical process. The lab sizes agitated nutsche filter dryer can be in glass (the GFD®) with 0.002m² to 0.05m² filtration areas. Larger filter dryers range from 0.05m² up to more than 2.5 m² filtration areas. They can be built to meet the strict manufacturing requirements of aseptic/sterile processes utilising gas lift-off mechanical seals, unique offloading designs, CIP and SIP (Steam-In-Place) capabilities.

PSL is proud of the robust performance of their filtration and drying systems and continually works closely with key partners and customers to accelerate process development and create the most reliable and ergonomic solutions. PSL has been supporting pharmaceutical, biopharmaceutical, chemical and laboratory industries for 23 years.

0.6m² agitated nutsche filter dryer with discharge glovebox in stainless steel from PSL.

Contacts
Powders Systems Limited (PSL)
Estuary Business Park
Liverpool
L24 8RG, UK
T: + 44 (0)151-448-7700
F: + 44 (0)151-448-7702
info@powdersystems.com
www.powdersystems.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
FindPharma Custom Search

Click here